Krónikus vesebetegség: vizsgálatok itt: Csehország
16 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 2026. november 12.. Ask the study team whether a trial fits you.
- 3. fázisTaking people"AMBITION 2: A research study investigating how well zenagamtide lowers blood sugar and body weight compared to placebo in people with type 2 diabetes and chronic kidney disease treated with once daily basal insulin alone or in combination with metformin, SGLT2i, or both."
- Where
- Chrudim, Prague, Prague 4, Prague 9
- Életkor
- 18 év and over
- People
- 95 worldwide
- Run by
- Novo Nordisk A/S
See details and how to join2026-525471-13-00 · EU 2026-525471-13-00 - 3. fázisTaking peopleA Phase III Renal Outcomes and Cardiovascular Mortality Study to Investigate the Efficacy and Safety of Baxdrostat in Combination With Dapagliflozin in Participants With Chronic Kidney Disease and High Blood Pressure
- Where
- Brandys nad Labem, Brandýs nad Labem, Frýdek-Místek, Jilemnice, Krnov, Mlada Boleslav, Náchod, Olomouc, Plzen 1, Prague, Prague 6, Praha 10, Slaný
- Életkor
- 18 év and over
- People
- 5000 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT06742723 · EU 2023-506460-14-00 - 3. fázisTaking peopleA Study of Orforglipron (LY3502970) on Cardiovascular Outcomes in Adults With Atherosclerotic Cardiovascular Disease and/or Chronic Kidney Disease (ATTAIN-Outcomes)
- Where
- Brandýs nad Labem, České Budějovice, Chlumec Nad Cidlinou Iv, Havířov, Jilove U Prahy, Krnov, Ostrava, Poštovní, Prague, Praha 1, Praha 6
- Életkor
- 50 év and over
- People
- 7140 worldwide
- Run by
- Eli Lilly and Company
See details and how to joinNCT07241390 · EU 2025-523123-22-00 - No phaseCsak meghívásosAssessment of Worldwide Acute Kidney Injury Epidemiology in Neonates 2.0
- Where
- Prague
- Életkor
- 0 Minutes to 2 hét
- People
- 8000 worldwide
- Run by
- Indiana University
See details and how to joinNCT06823115 - 3. fázisTaking peopleA Rollover Extension Program (REP) to Evaluate the Long-term Safety and Tolerability of Open Label Iptacopan/LNP023 in Participants With Primary IgA Nephropathy
- Where
- Prague
- Életkor
- 18 év to 100 év
- People
- 540 worldwide
- Run by
- Novartis Pharmaceuticals
See details and how to joinNCT04557462 · EU 2023-508690-92-00 - 3. fázisTaking peopleA Study to Learn More About How Safe the Study Treatment Finerenone is in Long-term Use When Taken With an ACE Inhibitor or Angiotensin Receptor Blocker Over 18 Months of Use in Children and Young Adults From 1 to 18 Years of Age With Chronic Kidney Disease and Proteinuria
- Where
- Prague, Prague 2
- Életkor
- 1 év to 18 év
- People
- 100 worldwide
- Run by
- Bayer
See details and how to joinNCT05457283 · EU 2023-504885-50-00 - 2/3. fázisTaking peopleCombined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD)
- Where
- Český Krumlov, Hradec Králové, Nový Jičín, Ostrava, Prague
- Életkor
- 18 év and over
- People
- 3110 worldwide
- Run by
- CSL Behring
See details and how to joinNCT05485961 · EU 2022-500273-14-00 - 3. fázisTaking peopleEfepoetin alfa for treatment of anemia in chronic kidney disease on dialysis
- Where
- Havlickuv Brod, Horni Brana, Plzen 1, Teplice
- Életkor
- 18 év and over
- People
- 337 worldwide
- Run by
- Genexine Inc.
See details and how to join2023-503634-50-01 · EU 2023-503634-50-01 - 3. fázisTaking peopleA Study to Investigate Outcomes With Elecoglipron Compared With Placebo in Adult Participants With Chronic Kidney Disease.
- Where
- Hradec Králové, Humpolec, Jejkov, Jilemnice, Liberec (Neclenene Mesto), Marianske Lazne, Náchod, Nove Mesto Na Morave, Nový Jičín, Ostrava, Prague, Prague 3, Prague 6, Tábor
- Életkor
- 18 év and over
- People
- 7000 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT07753993 · EU 2025-523994-41-00 - 3. fázisTaking peopleA Phase 3 Study of Etelcalcetide in Children With Secondary Hyperparathyroidism Receiving Hemodialysis
- Where
- Prague 5
- Életkor
- 2 év to 17 év
- People
- 24 worldwide
- Run by
- Amgen
See details and how to joinNCT03969329 · EU 2023-506471-10-00 - 3. fázisTaking peopleA Phase 3 Study of Efepoetin Alfa for Treatment of Anemia in Patients With Chronic Kidney Disease on Dialysis
- Where
- Český Krumlov, Havlíčkův Brod, Pilsen, Teplice
- Életkor
- 18 év and over
- People
- 429 worldwide
- Run by
- Genexine, Inc.
See details and how to joinNCT06466785 - No phaseTaking peopleInternational (Pediatric) Peritoneal Biobank
- Where
- Prague
- Életkor
- 1 nap to 90 év
- People
- 500 worldwide
- Run by
- Heidelberg University
See details and how to joinNCT01893710 - 2. fázisTaking peopleA Research Study Comparing How Well Different Doses of the Medicine NNC0519-0130 Can Reduce Kidney Damage in People Living With Chronic Kidney Disease
- Where
- Český Krumlov, Frýdek-Místek, Hodonín, Prague, Smiřice
- Életkor
- 18 év and over
- People
- 465 worldwide
- Run by
- Novo Nordisk A/S
See details and how to joinNCT06717698 · EU 2024-510846-15-00 - No phaseTaking peopleComparison of Individualized Sodium Management Versus Standard Treatment in Hemodialysis
- Where
- Mariánské Lázně
- Életkor
- 18 év and over
- People
- 130
- Run by
- Fresenius Medical Care Deutschland GmbH
See details and how to joinNCT06341452 - No phaseTaking peopleChronic Kidney Disease Screening
- Where
- Prague
- Életkor
- 18 év and over
- People
- 3000
- Run by
- Institute for Clinical and Experimental Medicine
See details and how to joinNCT07153432 - No phaseTaking peopleFetuin A as a Predictor of Deterioration of Renal Function in Hypertonic Patients
- Where
- Ostrava
- Életkor
- 18 év to 100 év
- People
- 200
- Run by
- University Hospital Ostrava
See details and how to joinNCT05963126